Angiotensin receptor blockers and myocardial infarctionBMJ 2005; 330 doi: http://dx.doi.org/10.1136/bmj.330.7502.1269 (Published 26 May 2005) Cite this as: BMJ 2005;330:1269
Analysis of evidence is incomplete and inaccurate
- John McMurray, professor of medical cardiology ([email protected])1
- 1Department of Cardiology, Western Infirmary, Glasgow G11 6NT
Editor—Verma and Strauss say that, compared with angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers do not reduce (and may increase) the risk of myocardial infarction.1 Their claim represents an incomplete, inaccurate, and misleading “analysis” of the evidence.
They did not cite the two largest studies that randomised patients to an ACE inhibitor or angiotensin receptor blockers and had the statistical power to evaluate cardiovascular outcomes.2 3 These had twice …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial